Free shipping on all orders over $ 500

OTS186935 trihydrochloride 

Cat. No. M29200

All AbMole products are for research use only, cannot be used for human consumption.

OTS186935 trihydrochloride  Structure

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

OTS186935 trihydrochloride is a protein methyltransferase SUV39H2 inhibitor with an IC50 of 6.49 nM. OTS186935 trihydrochloride shows significant inhibition of tumor growth in mouse xenograft models without any detectable toxicity. OTS186935 trihydrochloride regulates the production of γ-H2AX in cancer cells.

Chemical Information
Molecular Weight 573.34
Formula C25H29Cl4N5O2
CAS Number 2093401-85-3
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Related Histone Methyltransferase Products
VTP50469

VTP50469 is a potent, highly selective and orally active inhibitor of Menin-MLL Interaction with a Ki value of 104 pM. VTP50469 has anti-leukemia activity.

BIX 01294 Trihydrochloride

BIX 01294 Trihydrochloride is a potent inhitor of G9a histone methyltransferase with IC50 of 2.7 μM.

EBI-2511

EBI-2511 is an orally active, potent inhibitor of EZH2 in Pfeffiera cells IC50 The value is 6 nM.

EPZ-5676

EPZ-5676 is a potent and selective aminonucleoside inhibitor of DOT1L histone methyltransferase.

EPZ004777

EPZ004777 is a potent, selective, small-molecule inhibitor of DOT1L with IC50 of 0.4 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: OTS186935 trihydrochloride  supplier, Histone Methyltransferase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.